Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IART Integra LifeSciences	$14.12 +2.5%	$12.61	$11.06 ▼ $27.13	$1.10B	1.16	1.03 million shs	1.30 million shs
MMSI Merit Medical Systems	$86.15 +1.6%	$89.80	$81.04 ▼ $111.45	$5.10B	0.66	662,397 shs	466,505 shs
OFIX Orthofix Medical	$14.10 +2.2%	$11.22	$10.24 ▼ $20.73	$552.44M	0.82	322,322 shs	594,319 shs
SRDX Surmodics	$37.99 +0.2%	$31.61	$26.00 ▼ $40.38	$543.26M	1.31	178,301 shs	291,348 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IART Integra LifeSciences	+8.00%	+8.17%	+9.37%	+6.58%	-35.32%
MMSI Merit Medical Systems	+0.86%	+0.32%	-9.34%	-12.63%	-6.04%
OFIX Orthofix Medical	+6.65%	+12.10%	+24.89%	+15.29%	-13.97%
SRDX Surmodics	-0.21%	+7.09%	+22.84%	+35.77%	-7.60%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IART Integra LifeSciences	4.0268 of 5 stars	2.9	2.0	4.0	2.1	1.7	1.9
MMSI Merit Medical Systems	4.6304 of 5 stars	4.4	1.0	3.8	3.5	2.5	1.3
OFIX Orthofix Medical	2.28 of 5 stars	3.5	1.0	0.0	2.3	2.5	0.6
SRDX Surmodics	3.7119 of 5 stars	2.2	3.0	3.4	2.0	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IART Integra LifeSciences	1.78	Reduce	$18.63	33.51% Upside
MMSI Merit Medical Systems	2.89	Moderate Buy	$107.00	24.48% Upside
OFIX Orthofix Medical	3.00	Buy	$21.50	51.89% Upside
SRDX Surmodics	2.33	Hold	$43.00	12.77% Upside

Current Analyst Ratings Breakdown

Latest OFIX, MMSI, IART, and SRDX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	SRDX Surmodics	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
7/31/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$108.00 ➝ $100.00
7/31/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$110.00 ➝ $105.00
7/31/2025	MMSI Merit Medical Systems	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$108.00 ➝ $102.00
7/31/2025	MMSI Merit Medical Systems	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$103.00
7/18/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
7/16/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
7/8/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
6/23/2025	OFIX Orthofix Medical	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$16.00
6/6/2025	OFIX Orthofix Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IART Integra LifeSciences	$1.61B	0.67	$4.88 per share	2.86	$13.33 per share	1.05
MMSI Merit Medical Systems	$1.36B	3.75	$5.73 per share	14.99	$25.13 per share	3.42
OFIX Orthofix Medical	$799.49M	0.69	N/A	N/A	$11.70 per share	1.21
SRDX Surmodics	$126.08M	4.32	$0.31 per share	122.82	$7.79 per share	4.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IART Integra LifeSciences	-$6.94M	-$6.53	N/A	5.58	0.72	-30.87%	12.15%	4.32%	N/A
MMSI Merit Medical Systems	$120.36M	$1.97	43.65	22.92	2.75	8.31%	15.07%	8.60%	10/29/2025 (Estimated)
OFIX Orthofix Medical	-$126M	-$3.17	N/A	N/A	N/A	-15.29%	-25.43%	-14.46%	N/A
SRDX Surmodics	-$11.54M	-$1.23	N/A	47.66	N/A	-14.59%	-2.99%	-1.99%	N/A

Latest OFIX, MMSI, IART, and SRDX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/8/2025	Q3 2025	SRDX Surmodics	-$0.21	$0.06	+$0.27	-$0.37	$28.04 million	$29.57 million
8/5/2025	Q2 2025	OFIX Orthofix Medical	$0.04	-$0.36	-$0.40	-$0.36	$196.89 million	$203.12 million
7/31/2025	Q2 2025	IART Integra LifeSciences	$0.43	$0.45	+$0.02	-$6.31	$395.06 million	$415.61 million
7/30/2025	Q2 2025	MMSI Merit Medical Systems	$0.85	$1.01	+$0.16	$0.54	$372.47 million	$382.46 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A
SRDX Surmodics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IART Integra LifeSciences	1.18	1.23	0.73
MMSI Merit Medical Systems	0.49	4.09	2.66
OFIX Orthofix Medical	0.38	2.67	1.50
SRDX Surmodics	0.27	3.91	3.10

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IART Integra LifeSciences	84.78%
MMSI Merit Medical Systems	99.66%
OFIX Orthofix Medical	89.76%
SRDX Surmodics	96.63%

Insider Ownership

Company	Insider Ownership
IART Integra LifeSciences	3.54%
MMSI Merit Medical Systems	3.70%
OFIX Orthofix Medical	1.30%
SRDX Surmodics	8.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IART Integra LifeSciences	4,396	77.91 million	75.15 million	Optionable
MMSI Merit Medical Systems	7,400	59.22 million	57.03 million	Optionable
OFIX Orthofix Medical	1,616	39.18 million	38.67 million	Optionable
SRDX Surmodics	450	14.30 million	13.03 million	Optionable

OFIX, MMSI, IART, and SRDX Headlines

Recent News About These Companies

Barrington Research Predicts Weaker Earnings for Surmodics

August 13 at 8:35 AM | marketbeat.com

Wolverine Asset Management LLC Has $265,000 Holdings in Surmodics, Inc. (NASDAQ:SRDX)

August 13 at 4:15 AM | marketbeat.com

SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts

August 12 at 2:06 PM | zacks.com

Surmodics (NASDAQ:SRDX) Trading Up 8.7% on Better-Than-Expected Earnings

August 12 at 12:21 PM | marketbeat.com

Surmodics (NASDAQ:SRDX) Given Market Perform Rating at Barrington Research

August 12 at 8:34 AM | marketbeat.com

Barrington Research Reiterates "Market Perform" Rating for Surmodics (NASDAQ:SRDX)

August 12 at 3:47 AM | americanbankingnews.com

Surmodics (NASDAQ:SRDX) Shares Up 8.7% Following Strong Earnings

August 12 at 2:19 AM | americanbankingnews.com

SurModics: Hold Rating Amid Mixed Financial Performance and Legal Uncertainties

August 11 at 8:24 AM | tipranks.com

Surmodics (NASDAQ:SRDX) Issues Earnings Results, Beats Estimates By $0.27 EPS

August 10 at 2:51 PM | marketbeat.com

Surmodics (NASDAQ:SRDX) Issues FY 2025 Earnings Guidance

August 9, 2025 | marketbeat.com

Surmodics (NASDAQ:SRDX) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened

August 9, 2025 | marketbeat.com

SurModics: Balancing Strong Financial Performance with Acquisition Uncertainty

August 8, 2025 | tipranks.com

SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

August 8, 2025 | zacks.com

What's Next: Surmodics's Earnings Preview

August 8, 2025 | benzinga.com

SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates

August 8, 2025 | zacks.com

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

August 8, 2025 | businesswire.com

Surmodics (SRDX) Q3 EPS Turns Positive

August 8, 2025 | fool.com

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

August 6, 2025 | businesswire.com

Surmodics falls as parties, FTC ask for extension of briefing schedule

July 31, 2025 | msn.com

Surmodics (NASDAQ:SRDX) Sees Strong Trading Volume - What's Next?

July 29, 2025 | marketbeat.com

Burren Capital Advisors Ltd Purchases Shares of 35,846 Surmodics, Inc. (NASDAQ:SRDX)

July 27, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX, MMSI, IART, and SRDX Company Descriptions

Integra LifeSciences NASDAQ:IART

$14.12 +0.35 (+2.54%)

Closing price 04:00 PM Eastern

Extended Trading

$14.18 +0.06 (+0.45%)

As of 06:22 PM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Merit Medical Systems NASDAQ:MMSI

$86.15 +1.39 (+1.64%)

Closing price 04:00 PM Eastern

Extended Trading

$86.01 -0.14 (-0.17%)

As of 06:01 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Orthofix Medical NASDAQ:OFIX

$14.10 +0.30 (+2.17%)

Closing price 04:00 PM Eastern

Extended Trading

$14.10 0.00 (0.00%)

As of 05:39 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Surmodics NASDAQ:SRDX

$37.99 +0.07 (+0.18%)

Closing price 04:00 PM Eastern

Extended Trading

$37.98 -0.02 (-0.04%)

As of 05:32 PM Eastern

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time